Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00962039Phase 3Completed
Phase 3, randomised, double-blind trial in functional abdominal pain (FAP) comparing Citalopram with Placebo (2 arms). Primary endpoints: Clinical Global Impression Scale - Improvement at 8 weeks, Clinical Global Impression Scale - Severity at 8 weeks and 1 more. Started Jul 2004; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00962039.